RB1 and retinoblastoma: Patients with a 13q deletion containing RB1 show a variable phenotype that, depending on the size and location of the deleted region, includes ID, growth retardation, craniofacial dysmorphisms, congenital malformations, and increased risk of retinoblastoma.